Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph‐negative acute lymphoblastic leukemia relapsed post CD19 CART therapy. - Huang, Si‐Man; Wan, Chao‐Ling; Cao, Han‐Yu; Li, Yan‐Yan; Qian, Chong‐Sheng; Zhou, Hai‐Xia; Xu, Ming‐Zhu; Hu, Xiao‐Hui; Dai, Lan; Dai, Hai‐Ping; Xue, Sheng‐Li (Clinical Case Reports, 2023)